54 metastatic colorectal cancer patients from Schleswig-Holstein in North Germany
|Study ID||Alternative Stable ID||Type|
Personalized treatment vs standard of care is much debated, especially in clinical practice. Here we investigated whether overall survival differences in metastatic colorectal cancer patients are explained by their tumor mutation profiles or by their treatment differences in real clinical practice.
Study Datasets 0 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Who archives the data?